Jazz Pharmaceuticals JAZZ Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$368.44M-180% | -$404.8M-203% | $482.24M+45.8% | ||
| $40.34M+13.6% | $41.64M+27.1% | $41.72M+35.1% | $39.62M+28.7% | $35.5M+16.4% | ||
| $297.93M+17.2% | $291.13M+17.4% | $290.47M+25.9% | $262.1M+15.4% | $254.3M+9.6% | ||
| $1.33B-14.4% | $1.36B-2.9% | $1.39B+19.5% | $1.32B+22.6% | $1.56B+50.1% | ||
| $64.55M+43.2% | $58.75M+54.3% | $55.31M+58.5% | $50.92M+79.3% | $45.07M+66.6% | ||
| -$1.22B— | -$1.51B— | -$1.33B— | —— | —— | ||
| -$213.82M— | -$948.82M— | —— | —— | —— | ||
| —— | —— | —— | -$165.92M-326% | $418.48M+51.9% | ||
| $1.27B-16.1% | $1.3B-4.5% | $1.34B+18.3% | $1.27B+21.1% | $1.51B+49.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jazz Pharmaceuticals generate?
- Jazz Pharmaceuticals (JAZZ) generated $1.3B in operating cash flow over the trailing twelve months.
- What is Jazz Pharmaceuticals's free cash flow?
- After $64.6M of capital expenditures, Jazz Pharmaceuticals's free cash flow was $1.3B over the trailing twelve months, down 16.1% year over year.
- Where does Jazz Pharmaceuticals's cash flow data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
